Zenlabs Ethica Ltd is engaged in trading, marketing and distribution of pharmaceutical formulations.Business Overview: Zenlabs Ethica Ltd is a WHO-GMP certified, third party manufacturing pharma company. Company was launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. It is a part of Preet Remedies Group which has five manufacturing units namely...
Zenlabs Ethica has announced the publication of its financial results for the quarter ended June 30, 2025. The extract of these unaudited results has been published in Financial Express and Dainik Tribune newspapers. For complete financial details, investors can use the QR Code or web link provided in the advertisements,...
Zenlabs Ethica's Board has approved new policies to enhance corporate governance and transparency. This includes a Code of Fair Disclosure for unpublished price-sensitive information (UPSI) and a Code of Conduct for regulating insider trading. These policies aim to ensure timely and fair disclosure of UPSI, prevent its misuse, and monitor...
Zenlabs Ethica Limited has announced that no dematerialisation requests for its equity shares were received by its Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd., during the quarter ended June 30, 2025. This indicates no share conversions from physical to electronic form in this period, reflecting stable shareholder activity...
Zenlabs Ethica Ltd has announced that disclosure of related party transactions is not applicable for the half-year ended March 31, 2025. With a paid-up equity share capital of Rs. 6.51 Cr and net worth of Rs. 10.42 Cr, the company falls below certain thresholds, exempting it from filing related party...
Zenlabs Ethica Ltd has announced a board meeting on which it approved the audited financial results for the quarter and year ended March 31, 2025, with auditors providing unmodified opinions. The company has re-appointed M/s Jaspreet Dhawan & Associates as Secretarial Auditor and M/s Anu & Associates as Internal Auditor...
